Review article · 9 Jun 2025
Conference abstractPublished 28 Sep 2018
Transdermal delivery of pravastatin loaded microemulsion based drug delivery system developed by central composite design
University College of Pharmaceutical Sciences, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The present study involves the formulation and optimization of microemulsion based Transdermal therapeutic system to improve the bioavailability of Pravastatin, an antilipidemic agent. It is a low bioavailable drug (18%). Drug-Excipient compatibility studies were conducted by FTIR. Capmul MCM was screened as oil phase; Tween 80 and Transcutol P were selected as surfactant and co-surfactant for microemulsions, due to their good solubilizing capacity of Pravastatin. Water titration method was used for the preparation of microemulsions to construct pseudo-ternary phase diagrams by using Chemix software. The microemulsion was optimized using a three-factor, three-level Central composite design, the independent variables selected were oil (Capmul), surfactant mixture (Tween 80 and Transcutol) and water, dependent variables selected were the size (Y1), flux (Y2), and Zeta potential (Y3). Mathematical equations and response surface plots were used to relate the dependent and independent variables. The prepared microemulsions were evaluated for various physicochemical parameters, ex vivo permeation studies by using Franz diffusion cells. All parameters were within the acceptable limits. Optimized formulation composition was selected by feasibility and grid search. The optimized formulation was showed flux 86.6 (μg/cm2/h), Zeta potential-33.8±15 mV, size 38±1.8 nm. The permeation of optimized microemulsion formulation showed 4.1 folds higher flux when compared with drug solution (21.08μg/cm2/h). Validation of the optimization study with 6 confirmatory runs indicated the high degree of prognostic ability of response surface methodology. The microemulsion-based Transdermal therapeutic system of Pravastatin was developed and optimized using Central composite statistical design and could provide an effective treatment in the management of Hyperlipidemia.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pharmaceutical Care & Health Systems.
Research article · 8 Jun 2025
Formulation and Antibacterial Evaluation of Acmella olaracea (Akarkara) Gummies Used for Toothache
Research article · 9 Apr 2025
Deep Vein Thrombosis: A Closer Look at a Silent Threat
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutical Care & Health Systems
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Anjali Devi Nippani”
- BylineArticles whose byline prints “J Krishnaveni”
